|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
|
|---|---|---|---|
| Revenues | |||
| Cost of revenues | |||
| Gross profit | |||
| Operating expenses | |||
| General and administrative expenses | |||
| Selling and marketing expenses | |||
| Research and development expenses | |||
| Gain from disposal of property and equipment | |||
| Total operating expenses | |||
| Operating loss | |||
| Other (expenses) /income | |||
| Investment income | |||
| Interest income/(expenses), net | |||
| Fair Value Change in Derivative Liability | |||
| Impairment loss from equity investment | |||
| Interest (expenses)/income, net | |||
| Other non-operating income | |||
| Total other (expenses)/income, net | |||
| (Loss)/income before income taxes | |||
| Income tax (provision)/ benefit | |||
| Net loss | |||
| Other comprehensive income | |||
| Foreign currency translation adjustment | |||
| Total comprehensive loss attributable to the Company’s ordinary shareholders | |||
| Earnings per ordinary share attributable to ordinary shareholders | |||
| Basic (in Dollars per share) | |||
| Diluted (in Dollars per share) | |||
| Weighted average number of ordinary shares outstanding | |||
| Basic (in Shares) | |||
| Diluted (in Shares) |
Loading...